Privacy protected and anonymized by ShouldEye. No AI training. Learn more

Official company dossier

Enable Medicine

AI Expert

Biotechnology Companiesenablemedicine.comUS

AI Trust Score, Reviews & Company Verification

Ownership opportunity

Is this your company? Claim the Enable Medicine profile to verify ownership and manage company-provided details.

Independent company assessment

8.5/10B · Solid

22 indexed evidence signals reviewed

AI Comparison

Safe Entity66% Confidence

Based on 5 polled AI models

  • GeminiGoogle DeepMind
    Safe80%Confidence
  • GrokxAI
    Safe68%Confidence
  • DeepSeekDeepSeek
    Safe90%Confidence
  • GLMZ.ai
    Safe45%Confidence
Updated Jul 29

Key stats

Sector
Biotechnology Companies
Headquarters
US
Domain
enablemedicine.com
Domain history
Not available
Risk tier
Moderate
Assessed
Jul 29, 2026
From the Brand Unclaimed

Enable Medicine hasn't claimed this profile yet

ShouldEye AI builds this page from public sources. Nothing here is approved by Enable Medicine.

  • Reply to reviews
  • Publish your brand message
  • Earn the trust seal

Claiming gives you a voice, not control of the trust score.

Free for verified company teams

About

Enable Medicine is a biotechnology company that creates detailed biological maps and cellular atlases to accelerate drug discovery, leveraging generative AI and spatial biology technologies.

Headquarters
US
EyeQ
EyeQ AI Live

Full intelligence report for Enable Medicine

High confidence

Enable Medicine demonstrates strong operational credibility through exceptional regulatory compliance, consumer reviews, and customer service, supported by responsible advertising practices that reinforce its verified status. Its legal and privacy frameworks are comparatively moderate, suggesting room for improved policy transparency or data protections that keep the overall profile from matching the strength of its reputation and consumer-facing operations.

Strengths
  • The regulatory intelligence found no direct enforcement actions or compliance failures specific to Enable Medicine.
  • Public reputation is strong, highlighted by acquisition by General Inception and strategic partnerships with General Inception and BioChain, and recognition as a leader in AI‑led biological data analysis for drug discovery.
  • The Terms of Use provide a clear and accessible cancellation process for automatic renewals and transparent fee disclosures.
Key Risks
  • The Terms of Service contain one‑sided provisions: mandatory binding arbitration with class‑action and jury‑trial waivers (except a limited small‑claims carve‑out), broad indemnification shifting legal costs to users, unilateral term modifications without explicit notice, a perpetual license to user data for R&D and sublicensing, and a low liability cap of $100 or one month’s fees.
  • The privacy policy shares personal data with third‑party advertising and marketing partners for interest‑based advertising and profiling, collects general location information without explicit consent, lacks defined data retention periods, and does not disclose or allow opt‑out for using personal data to train AI/ML models.
  • The policy provides limited mechanisms for data deletion, requiring users to contact the company rather than offering self‑service deletion for all data, and does not specify clear breach notification procedures.
Domain & infrastructure
GoDaddy.com, LLCDomain registrar
—Domain age
5 assetsVerified assets
Contact & Support

Connect with Enable Medicine

Find us across the web

enablemedicine.com
  • Instagram
  • TikTok
  • YouTube
  • Facebook
  • X
  • LinkedIn
  • Threads
  • Pinterest
  • Snapchat
  • Reddit
  • Discord

No social profiles found yet.

People Behind Enable Medicine

Public-facing leadership and ownership signals for Enable Medicine — synthesized from verified profiles and corporate disclosures where available.

B
Brad Nelson
Chief Executive Officer
A
Aaron Mayer, PhD
Chief Scientific Officer
S
Sunil Bodapati
Chief Executive Officer